Protein-Protein Interaction between G protein-coupled receptors and heterotrimeric G proteins
AbstractG protein-coupled receptors (GPCRs) interact directly with heterotrimeric G proteins to transduce physiological signals. Early studies of this interaction concluded that GPCRs (R) and G proteins (G) collide with each other randomly after receptor activation and that R-G complexes are transient (collision model). More recent studies have suggested that inactive R and G are preassembled as stable R-G complexes in cells (preassembly models). Using fluorescence recovery after photobleaching (FRAP) we examined the stability of complexes formed between cyan fluorescent protein-labeled a2Aadrenoreceptors (C-a2ARs) and G proteins in HEK293 cells. Labeled G proteins diffused in the plasma membrane with equal mobility in the absence and presence of immobile C- a2ARs. In contrast, a stable R-G interaction was detected when G proteins were deprived of nucleotides and C- a2ARs were active. Over-expression of regulator of G protein signaling 4 (RGS4) accelerated the onset of effector activation but did not alter the interaction between C- a2ARs and G proteins. At most a small fraction of C- a2ARs and G proteins exist as R-G complexes at any moment. However, applying similar technique and protocols, we demonstrated that immobilized M3R specifically decreases the mobility of Gaq heterotrimers on the plasma membranes of intact HEK293 cells, suggesting the existence of R-G preassembly. The C-terminus of M3R was determined to be both required and sufficient for preassembly. The M3R C-terminus contains a polybasic region (565KKKRRK570) located distal to the 8th a-helix domain. Substitution of this polybasic region with 6 electroneutral alanines (M3R6A) prevented preassembly. Permeabilization of cells with low ionic strength buffer resulted in enhanced R-G interaction, implicating electrostatic forces as a factor in the preassembly. We examined the functional properties of the mutant M3R6A, which showed decreases in acetylcholine potency compared with M3R. M3R6A produced active Gq at half the rate of M3R. Other Gq-coupled receptors, such as M1 and M5 muscarinic and a1a,a1b, aid adrenergic receptors, contain similar C-terminal polybasic regions. We found that both M5R and alb adrenoceptor (albAR) preassembled with Gq proteins. Our findings suggest that a polybasic regionmediated electrostatic mechanism could be a common mechanism of preassembly between Gq-coupled receptors and Gq proteins.
AffiliationDepartment of Pharmacology and Toxicology
Showing items related by title, author, creator and subject.
Significance of Small Heat Shock Proteins HSPB1 and HSPB5 in Aggregation and Degradation of Amyloid ProteinsOjha, Juhi; Department of Biochemistry and Molecular Biology (2011-06-10)Molecular chaperones protect cells from the deleterious effects of protein misfolding and aggregation. Neurotoxicity of amyloid-beta (Ap) aggregates and its deposition in senile plaques are hallmarks of Alzheimer's disease (AD). We observed that the overall content of aB-crystallin, a small heat shock protein molecular chaperone, decreased in AD model mice in an age-dependent manner. We hypothesized that aB-crystallin protects cells against Ap toxicity. To test this, we crossed aB-crystallin/HspB2 deficient (CRYAB'A HSPB2'A) mice with AD model transgenic mice expressing mutant human amyloid precursor protein. Transgenic and non-transgenic mice in chaperone-sufficient or deficient backgrounds were examined for representative behavioral paradigms for locomotion and memory network functions - (i) spatial orientation and locomotion was monitored by open field test; (ii) sequential organization and associative learning was monitored by fear conditioning and (iii) evoked behavioral response was tested by hot plate method. Interestingly, aB-crystallin/HspB2 deficient transgenic mice were severely impaired in locomotion compared to each genetic model separately. Our results highlight a synergistic effect of combining chaperone deficiency in a transgenic mouse model for AD underscoring an important role for chaperones in protein misfolding diseases.
eNOS Regulation by Phosphorylation and Protein-Protein InteractionsLi, Chunying; Vascular Biology Center (2006-08)Endothelial nitric oxide synthase (eNOS) catalyzes the conversion of L-arginine to L-citrulline and nitric oxide (NO). Protein phosphorylation and protein-protein interactions are two major mechanisms for eNOS regulation at the post-translational level, three aspects of which have been investigated in this study. The first aspect of eNOS regulation that we have examined is whether endostatin (ES) is a novel eNOS-activating agonist responsible for stimulating multi-site eNOS phosphorylation in endothelial cells. We show that ES induces acute endothelial NO release accompanied by eNOS phosphorylation events in cultured bovine aortic endothelial cells (BAECs). ES also induces relaxation of rat aortic rings. The second aspect of eNOS regulation that we have examined is the role of individual eNOS serine and threonine phosphorylation sites in the regulation of eNOS activity in BAECs. We mutated all five Thr- and Ser- sites of eNOS phosphorylation to aspartate or alanine and overexpressed the proteins in BAECs using adenoviral-mediated gene transfer. We show that mimicking phosphorylation of Ser-116 and Thr-497 is inhibitory, and mimicking phosphorylation of Ser-617, Ser-635 and Ser-1179 is stimulatory. Mimicking phosphorylation of Ser-635 and Ser-1179 together does not show synergistic effects on endothelial NO release. In addition, removal of any of the five Ser/Thr phosphorylation sites does not affect thapsigargin- or VEGF-stimulated NO release. A final aspect of eNOS regulation that we have investigated is the role of protein-protein interactions of eNOS with the CAT (cationic amino acid transporter)-1 arginine transporter. We show that eNOS interacts directly with CAT-1 and that overexpression of CAT-1 proteins in BAECs results in significant increases in NO release which is not altered by the CAT-1 inhibitor, L-lysine, suggesting that NO production in this in vitro model is independent of CAT-1 mediated arginine transport. Furthermore, eNOS enzymatic activity is increased in lysates of CAT-1-overexpressing cells accompanied by increased eNOS association with CAT-1, alterations of eNOS phosphorylation and eNOS association with caveolin-1. The present study adds to the knowledge of the regulation of eNOS by multi-site phosphorylation and protein-protein interactions.
The Mechanism of Protein Kinase C in regulation of ATPase family AAA-domain Containing Protein 3A in Head and Neck Squamous Cell CarcinomaChemmalakuzhy, Ron; Department of Biological Sciences (Augusta University, 2018-12)One of the most important challenges of cancer treatment is inhibition of the metastasis of head and neck squamous cell carcinoma (HNSCC). HNSCC is a form of squamous cell carcinoma (SCC) that is localized in the mucosa] linings of the nose, mouth, and throat areas. HNSCC has a mortality rate of 350,000 deaths per year and approximately 630,000 new patients are diagnosed annually. The ATPase family AAA-domain containing protein 3A (ATAD3A) is a nuclear-encoded mitochondrial enzyme that has been identified to be highly expressed and associated with poor survival in I-INSCC patients. ATAD3A is involved in various cellular processes including mitochondrial dynamics, cell growth, cholesterol metabolism, and communication between endoplasmic reticul um and mitochondria. Although ATAD3A has been shown to act as a crucial regulator promoting head and neck cancer cell invasion and metastasis, the precise mechanism by which ATAD3A is upregulated in HNSCC cells is largely unknown. In this study, we elucidate for the first time that Protein Kinase C (PKC) enhances tumor promoting activity in HNSCC cells through regulating ATAD3A expression levels. The study uncovers the biological effects of PKC regulation in HNSCC cells, providing a strong rational basis for the design of novel therapeutic regimens by inhibition of ATAD3A in order to eventually increase cure rate in patients diagnosed with HNSCC.